OK so at $1.75 its gone vertical but I really think this share is just getting started. Given that the drug they are delivering is proven and it's just the delivery technique the risk of performance failure is pretty low and the addressable market is going to be massive.
Also allow for the fact they only use half go the active ingredient so their ability to be competitive is pretty damn good.
Bugger all supply and massive demand. It's looking healthy right now because I think most people can appreciate its potential upside. DYOR
Revenue - what does it look like?, page-51
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.025(1.50%) |
Mkt cap ! $143.2M | |||
| Open | High | Low | Value | Volume |
| $1.70 | $1.74 | $1.66 | $526.1K | 310.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7490 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 9625 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| LTP (ASX) Chart |